Search results
AstraZeneca PLC (OTCMKTS:AZNCF) Sees Large Drop in Short Interest
ETF DAILY NEWS· 9 hours agoAstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest ...
Why AstraZeneca plc (NASDAQ:AZN) is Investors’ One of Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since AstraZeneca ...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance· 3 hours agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance via AOL· 2 hours agoAstraZeneca (AZN) has long been in the oncology and other disease spaces, but rose to popularity in...
Ethic Inc. Grows Stake in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 1 day agoEthic Inc. lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 10.7% in the 4th quarter, according to its most recent 13F filing ...
AstraZeneca CEO gifts shares to family, no sale involved By Investing.com
Investing.com· 1 day agoAstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN) disclosed in a recent regulatory filing with the...
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 4 days agoAstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering ...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 3 hours agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 9 hours agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 19 hours agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children 10 and older. Farxiga, which goes by generic ...